Asthma trials recruiting in Texas

All Asthma trials nationally

Cities in Texas

Recruiting trials in Texas

• A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
  NCT07532265 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Dallas, Houston, San Antonio
• A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283
  NCT07712393 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Texas: Austin
• A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
  NCT07525375 · Phase: Phase 2 · Ages: 4 Years to 11 Years · Sex: All (male and female) · Texas: Lewisville, San Antonio
• A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
  NCT06664619 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Texas: Austin, Corsicana, Cypress, Dallas
• A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
  NCT07556159 · Phase: Not specified · Ages: 6 Years and older · Sex: All (male and female) · Texas: Dallas, El Paso, Houston, Hurst
• A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
  NCT07456033 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Texas: San Antonio
• A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
  NCT07323654 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Dallas, McKinney
• A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
  NCT05757102 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Texas: Dallas, Kerrville, Plano, Waco
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
  NCT07276724 · Phase: Phase 3 · Ages: 12 Years to 80 Years · Sex: All (male and female) · Texas: Amarillo, Baytown, Dallas, Houston
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
  NCT07359846 · Phase: Phase 3 · Ages: 12 Years to 80 Years · Sex: All (male and female) · Texas: San Antonio, Sugar Land
• A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
  NCT06023589 · Phase: Phase 3 · Ages: 5 Years to 11 Years · Sex: All (male and female) · Texas: Coppell, Dallas, Frisco, Houston
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
  NCT06977581 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: Boerne, Cypress, Dallas, Houston
• Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
  NCT07196436 · Phase: Not applicable (e.g. observational or device study) · Ages: 5 Years and older · Sex: All (male and female) · Texas: Arlington, Plano
• Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
  NCT06979323 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: McKinney
• Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
  NCT06932263 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Boerne, Dallas, El Paso
• ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
  NCT07301255 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: McKinney
• Escitalopram in Asthma Patients With Frequent Exacerbation
  NCT06216535 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Dallas
• Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
  NCT06307665 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Texas: Austin, Baytown, Beaumont, Bellaire
• Individualizing Treatment for Asthma in Primary Care (Full Study)
  NCT07052942 · Phase: Phase 4 · Ages: 13 Years to 75 Years · Sex: All (male and female) · Texas: Fort Worth, Houston
• Metformin IN Asthma for Overweight and Obese Individuals (MINA)
  NCT06273072 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Texas: Austin, Dallas, Houston
• Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma
  NCT07665892 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Texas: San Antonio
• Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
  NCT06750289 · Phase: Phase 3 · Ages: 12 Years to 75 Years · Sex: All (male and female) · Texas: Houston, McKinney, San Antonio
• Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
  NCT07228026 · Phase: Not specified · Ages: 5 Years to 100 Years · Sex: All (male and female) · Texas: Austin, Dallas, El Paso
• Viral Mucosal Reprogramming
  NCT05331170 · Phase: Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Texas: Galveston